← Back to Search

Remote Blood Pressure Monitoring for High Blood Pressure

N/A
Waitlist Available
Led By Catherine Sarkisian, MD, MSHS
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 18 years and older
Takes zero or three anti-hypertensive prescriptions (can include pills with 2 different drugs so could be on 2 medications)
Must not have
Other secondary causes of hypertension
Chronic kidney disease (CKD) Stage 3b (CrCL < 45) and above
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, six months
Awards & highlights

Summary

This trial is testing two ways to help people with hypertension monitor their blood pressure at home, to see if it can help lower blood pressure overall.

Who is the study for?
This trial is for adults with high blood pressure who use a non-connected blood pressure cuff at home, take up to three antihypertensive medications, and can access an online healthcare portal. They should have had two high BP readings in the last year and seen their primary care physician within that time. People with severe hypertension or certain health conditions like advanced kidney disease or recent heart problems cannot participate.Check my eligibility
What is being tested?
The study compares two remote monitoring methods for managing high blood pressure: one where patients manually record their BP and report it, versus another where the readings are automatically sent to their health system. The goal is to see which method better controls blood pressure across different University of California locations.See study design
What are the potential side effects?
Since this trial focuses on monitoring methods rather than medication changes, side effects are not a primary concern here. However, participants may experience stress or inconvenience related to using the technology or any potential technical issues.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I take up to three blood pressure medications.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have high blood pressure due to another health condition.
Select...
My kidney function is reduced but not severely (Stage 3b or better).
Select...
My thyroid condition is not under control.
Select...
I have not had a heart attack or similar event in the last 3 months.
Select...
I have a heart block or irregular heartbeat.
Select...
I am not currently in hospice or receiving end-of-life care.
Select...
I have been diagnosed with pheochromocytoma.
Select...
I often have very low blood pressure.
Select...
I have been diagnosed with severe narrowing of the aortic valve.
Select...
I have a narrowed artery to my kidney.
Select...
I have been diagnosed with Conn's syndrome.
Select...
My kidneys are in the final stage of failure.
Select...
I am already getting help for my high blood pressure from another service.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, six months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, six months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Continuous change in blood pressure (BP)
Secondary outcome measures
Body Weight Changes
Binary measure of controlled vs uncontrolled hypertension
Changes in blood pressure (BP) outcomes from integrated monitor readings
+1 more
Other outcome measures
Adverse events

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: IntegratedExperimental Treatment1 Intervention
Participants will have their home blood pressure readings sent directly to their participating health systems. Participants will also receive a wrap-around intervention.
Group II: ManualActive Control1 Intervention
Participants will record their own blood pressures and report them to their health care system as per usual care.

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,541 Previous Clinical Trials
10,266,383 Total Patients Enrolled
University of California Office of the President- Quality and Population Health ManagementUNKNOWN
University of California, DavisOTHER
919 Previous Clinical Trials
4,720,232 Total Patients Enrolled

Media Library

integrated monitoring and local wrap-around hypertension program Clinical Trial Eligibility Overview. Trial Name: NCT05390502 — N/A
High Blood Pressure Research Study Groups: Manual, Integrated
High Blood Pressure Clinical Trial 2023: integrated monitoring and local wrap-around hypertension program Highlights & Side Effects. Trial Name: NCT05390502 — N/A
integrated monitoring and local wrap-around hypertension program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05390502 — N/A
High Blood Pressure Patient Testimony for trial: Trial Name: NCT05390502 — N/A
~293 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top